SANDOZ RIVASTIGMINE PATCH 5
SANDOZ CANADA INCORPORATED
Quick answers
Is there a shortage of SANDOZ RIVASTIGMINE PATCH 5 in Canada?
No. There is no current shortage of SANDOZ RIVASTIGMINE PATCH 5 4.6MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MYLAN-RIVASTIGMINE PATCH 5
MYLAN PHARMACEUTICALS ULC
Other Products
SANDOZ RIVASTIGMINE PATCH 10
SANDOZ CANADA INCORPORATED
EXELON PATCH 10
KNIGHT THERAPEUTICS INC.
MYLAN-RIVASTIGMINE PATCH 10
MYLAN PHARMACEUTICALS ULC
EXELON PATCH 15
KNIGHT THERAPEUTICS INC.
EXELON
KNIGHT THERAPEUTICS INC.
DIN
02426293
Strength
4.6MG
Dosage Form
Patch
Route
Transdermal
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759